The CTSA program was developed to accelerate new treatments from the lab to patients, enabled to a large extent by patients participating in and benefiting from clinical trials. Clinical trials provide that needed bridge from human subjects to hypotheses to treatments that can directly benefit human health. And, never has this connection been more critical […]
June is National Alzheimer’s and Brain Awareness month. Scientists supported by the CTSA Program are contributing important research to help patients with neurodegenerative diseases.
Vaccines likely induce strong, persistent immunity to COVID-19
COVID-19 drugs, vaccines still effective against mutating virus
Challenge of measuring impact Government, non-profits, and organizations fund research with the ultimate goal of improving health and society. Yet measuring these long-term outcomes can be challenging, and research impact has traditionally been tied to quantitative productivity, like bibliometrics and grant funding, and not necessarily the broader impacts of research. For years, researchers lacked a […]